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Cerebrospinal fluid (CSF) contains growth and neurotrophic factors which regulate proliferation, differentiation, and neurogenesis. 
Thyroid hormones play a  crucial role in the development of the nervous system and hypothyroidism during development of 
embryos leads to defects in the nervous system. This study aimed to survey the effects of rat neonatal CSF collected from induced 
hypothyroid mothers on differentiation of bone marrow mesenchymal stem cells (BM‑MSCs). We hypothesized that hypothyroidism 
affected levels of growth factor in CSF. To induce hypothyroidism, pregnant Wistar rats received methimazole at the third day 
of gestation. BM‑MSCs were obtained from rat femurs and tibias and cultured in medium. CSF was collected from the cisterna 
magna of newborn rats, and cells were subsequently exposed to CSF with concentrations of 5,7, and 10 /100 (v/v) for 72  h. 
MTT  (3‑(4,5‑dimethylthiazol‑2‑yl)‑2,5‑diphenyltetrazolium bromide) assay and real time polymerase chain reaction  (RT‑PCR) were 
used to quantify the cell viability and analyze the expression of neural markers, respectively. Our morphological studies showed that 
treatment with hypothyroidism CSF (HTH‑CSF) resulted in a significant decrease in neurite growth and proliferation as compared to 
normal CSF (N‑CSF). RT‑PCR analysis also showed a significant decrease in expression of neural markers (i.e., Nestin, Neurod‑1, NeuN) 
in cells treated with HTH‑CSF as compared with the N‑CSF group. The most effective concentration of CSF for BM‑MSC differentiation 
was 5% (V/V). Our results showed a significant decrease in differentiation of BM‑MSCs in the presence of neonatal CSF of hypothyroid 
mothers compared with neonatal CSF of healthy mothers. Thus, thyroid hormones are essential in neural development and 
hypothyroid defects can affect development of the neonatal brain.
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INTRODUCTION
Thyroid hormone (thyroxine, T4) and its active de‑
iodinated derivative, 3,5,3‑triiodo‑L‑thyronine (T3) are 
important regulators for neural development of ver‑
tebrates which function in the brain by binding to T3 
nuclear receptors (Chatonnet et al., 2011). In humans, 
the fetal thyroid gland is not formed until the second 
trimester of gestation and in rodents it is not function‑
al until the 17th day of pregnancy. Importantly, thy‑
roid hormones pass easily through the placenta and 
the growing embryo relies on the mother for thyroid 
hormones during the first half of pregnancy (Sahay et 
al., 2012). When pregnancy is accompanied by hypothy‑
roidism, an array of unexpected problems are possible 
for both the mother and fetus (Sahay and Nagesh, 2012). 
T4 and T3 ligand regulate neural differentiation and 
control dendritic and axonal growth, neural cell migra‑
tion, synaptogenesis, myelination, and signaling (Ber‑
nal, 2015). Previous investigations have reported that 
hypothyroidism during critical phases of brain develop‑
ment in fetal and neonatal life lead to various changes 
in the pattern of migration, and result in reduced cell 
number and myelination in cerebellum, neocortex, and 
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hippocampus (Mussa et al., 2001). Other studies have 
revealed an interaction between thyroid and growth 
factors during development (Ahmed, 2018), which, ac‑
cording to our research, suggests that thyroid hormone 
deficiency affects growth factors level in the CSF. CSF 
contains cytokines, retinoic acid (RA), and diffusible 
factors such as transforming growth factor‑ß (TGF‑ß), 
nerve growth factor (NGF), brain derived neurotrophic 
factor (BDNF), insulin‑like growth factor, and neurotro‑
phin‑3 which can regulate the survival, proliferation, 
and differentiation of neuroepithelium. Neurotroph‑
ins modulate various developmental processes such as 
neural differentiation in the adult and developing ner‑
vous system of vertebrates (Nabiuni et al., 2015). These 
factors have been shown to be involved in some brain 
functions such as connectivity of neurons and neurite 
outgrowth (Yoshi et al., 2010). Meanwhile, the effect of 
thyroid hormone on development of nervous system is 
mediated via growth factors such as NGF and epidermal 
growth factor (Fisher et al., 1982). CSF has a prominent 
function in regulating the behavior of neuroprogenitor 
cells (Yari et al., 2012). Self‑renewal and lineage com‑
mitment of mesenchymal stem cells have shown to be 
influenced by several factors, including morphogenet‑
ic factors, TGFs, RAs, and other small molecules (Nava 
et al., 2012). As mentioned above, hypothyroidism has 
negative effects on both mother and fetus. Thus, it is 
important to study the effects of maternal hypothy‑
roidism on CSF of neonates and also the effects of CSF 
from hypothyroidism mothers on neural cell prolifera‑
tion and differentiation. The main aim of our study was 
to investigate the effect of neonatal CSF obtained from 
hypothyroid mothers on neural differentiation of bone 
marrow mesenchymal stem cells (BM‑MSCs), to better 
understand the abnormality of hypothyroid CSF.
METHODS
Animals
Wistar rats were bred in the Animal Center and Cel‑
lular and Molecular Research Laboratory, Kharazmi 
University. The animals were kept in standard condi‑
tions at a constant temperature with a 12‑hour light/
dark cycle and free access to food and water. All an‑
imals were treated in compliance with the guidelines 
for Ethical Committee for the care and use of animals 
approved by our university, in accordance with the 
principles of laboratory animal care (NIH Guide for the 
Care and Use of Laboratory Animals, Institute of Lab‑
oratory Animal Resources, National Research Council, 
Washington, D.C). Mating was induced by housing in‑
dividual females with a male (200 ‑ 250 g) in a separate 
mating cage. Day zero of gestation (GD) was determined 
by observation of the vaginal plaque. CSF was collect‑
ed from newborn rats following our previous protocol 
(Nabiuni et al., 2012). 
Preparation of hypothyroid rats
In this study, pregnant rats (n=40) from the third 
day of gestation (GD3) to the first day of postpartum 
(PN0) were allocated into one of two groups: euthyroid 
(normal control) and hypothyroid rats. Hypothyroid‑
ism was induced by administration of Methimazole 
(MMI) (Darupakhsh, Iran) in drinking water (50 ppm) 
from the third day of gestation to the first postpartum 
day (GD3‑PN0). Control rats received only tap water. 
CSF collection from newborn Wistar rats
CSF specimens were collected from the cisterna 
magna of euthyroid and hypothyroid newborn rats us‑
ing glass micropipettes into sterile tubes. Specimens 
were centrifuged at 1400 rpm for 5 min to remove the 
remaining cells and debris. Supernatant was trans‑
ferred into another sterile micro tube and immediately 
stored at ‑80°C (Nabiuni et al., 2012).
Isolation and expansion of BM‑MSCs
BM‑MSCs were harvested from the femur and tibia 
of 4 to 6 week old male rats weighing 100 ‑ 150 g. Briefly, 
stromal cell suspension of bone marrow was prepared 
by flushing the femurs and tibias in Dulbecco’s modi‑
fied Eagle’s medium (DMEM) supplemented with 15% 
fetal bovine serum (FBS) and 1% pen/strep using a sy‑
ringe needle. The cell suspension was then centrifuged 
at 15000 rpm for 5 min, and subsequently cultured in 
25 cm2 flasks. The adhered cells from the third passage 
were used to be treated with CSF (Shokohi et al., 2017).
Treatment of BM‑MSCs using CSF
BM‑MSCs were seeded in 96‑well plates with a cell 
density of 2 × 104/cm2 and the media renewed every 
two days. Then, cells were treated using N‑CSF and 
HTH‑CSF. To determine the most effective concentra‑
tion of CSF, cells cultured in DMEM, 3% FBS and 1% pen/
strep were exposed to different concentrations of CSF 
[i.e., 5 ,7 and 10 /100 (v/v)] for a week. One concentra‑
tion was selected as yielding the optimum CSF concen‑
tration (Shokohi et al., 2017).
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Morphological properties and neurite‑like 
processes assessment
To evaluate the morphology and growth rate of 
BM‑MSCs, cell culture plate photography was per‑
formed using an inverted microscope (Olympus, To‑
kyo, Japan) and the images were analyzed by ImageJ 
software (NIH, version 1.51). The cell morphology and 
length of neurite‑like processes was compared between 
cell treatments (Shokohi et al., 2018). 
Cell proliferation assay
MTT assay is a colorimetric test for measuring cell 
proliferation and metabolic activity. MTT (3‑(4,5‑di‑
methylthiazol‑2‑yl)‑2,5‑diphenyl tetrazolium bromide) 
is a yellow tetrazolium dye that in responding to acti‑
vated mitochondrial dehydrogenases changes to dark 
blue formazan crystals. The effective CSF dosage and 
survival rate of cells were evaluated. BM‑MSCs were 
exposed to HTH‑CSF and N‑CSF with concentrations of 
0, 5%, 7%, 10 % (v/v) for 72 h. Next, the cells were incu‑
bated with MTT (5 mg/mL in PBS, Merck, Germany) at 
37°C for 3 h. The formed formazan crystals were then 
dissolved in dimethyl sulfoxide (DMSO) (Sigma) and ab‑
sorbance was measured at 570 nm via a plate reader 
(Stat fax 2100, USA) (Shokohi et al., 2018).
Quantitative real‑time PCR (qRT‑PRCR)
To investigate the neural differentiation of BM‑MSCs, 
real time PCR was performed to evaluate the expression 
of neural markers. Total RNA was isolated from treated 
and non‑treated cells and neural markers were evalu‑
ated using RNX Plus TM (Cinagen, Iran). First‑strand 
cDNA was synthesized by cDNA Synthesis Kit (Fermen‑
tas, Lithuania). Quantitative PCR amplification was 
performed using SYBR green PCR master mix (Applied 
Biosystems, Foster City, CA, USA) in a thermocycler 
(Applied Biosystems). The amplification procedure was 
carried out for 40 cycles, first at 95°C for 10 min, then 
at 95°C for 15 sec and finally at 60°C for 1 min in each 
cycle (Zheng et al., 2017). The mRNA expression of neu‑
ral markers including Nestin, neurogenic differentiation 
1 (Neurod‑1) and neuronal nuclei (NeuN) or (BRFOX3) was 
examined using the primer sets outlined in Table I. 
Statistical analysis
Statistical analysis was performed using SPSS Soft‑
ware and p<0.05 was considered significant. Data are 
represented as the mean ± standard error of the mean 
(SEM). One‑way ANOVA and Tukey post hoc tests were 
used to analyze the data.
RESULTS
MTT assay
Results of the MTT test showed higher cell via‑
bility in control and N‑CSF groups as compared with 
the HTH‑CSF group. More importantly, cells that were 
treated with 5% HTH‑CSF showed a more significant in‑
crease in viability as compared to cells treated with 7% 
and 10% HTH‑CSF (Fig. 1).
Morphological study
Morphological analysis of BM‑MSCs showed long 
spindle‑shaped cells with oval‑shaped nuclei. While 
N‑CSF treatment resulted in long and thin neurites in 
BM‑MSCs after a week, HTH‑CSF showed a less sim‑
ilar morphology to neural‑like cells. Thus, HTH‑CSF 
induced less proliferation and greater cell degenera‑
tion as compared to N‑CSF. Microscopic observations 
showed cell death in cells treated with 7% and 10% 
(V/V) HTH‑CSF (Fig. 2).
Measurement of neurite outgrowth
ImageJ analysis showed minimum neurite out‑
growth in non‑treated BM‑MSCs (i.e., controls). The 
Table I. Primer sequences for qRT‑PCR.
Gene name Forward primer sequence (5’‑3’) Reverse primer sequence (3’‑5’) Product length
Neurod‑1 CCTACTCCTACCAGTCCCCT CAAACTGGATGGTTCG 228
Nestin GTTTTGGGTAAGAGCTGGCC TCCTAGCCCCATACT 232
NeuN (RBFOX3)  AGTGSSTSTGCCCCACCTC GGTGGTTGCTGGCTATCT 209
GAPDH CAAATTCCATGGCACCGT C TCTCGCTCCTGGAAGATGGT 62
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BM‑MSCs exposed to HTH‑CSF had significantly less 
neurite outgrowth, on average, as compared to the 
N‑CSF‑treated cells. Maximum neurite outgrowth was 
observed in N‑CSF‑exposed cells (Fig. 3). 
qRT‑PCR
Expression of Neurod‑1was significantly lower in 
BM‑MSCs exposed to HTH‑CSF as compared with con‑
trols (P≤0.001). Nestin expression, in contrast, was 
significantly higher in BM‑MSCs exposed to HTH‑CSF 
as compared to controls (P<0.01), and no significant 
changes in NeuN were observed as compared with con‑
trols. Altogether, HTH‑CSF resulted in a significant de‑
crease in the expression of Nestin, Neurod‑1 and NeuN as 
compared with N‑CSF (P≤0.001). As compared to con‑
trols, cells treated with N‑CSF showed an increased in 
mRNA expression (i.e., P≤0.001 for Nestin and NeuN and 
P≤0.01 for Neurod‑1) (Fig. 4). 
Fig. 2. Morphology of bone marrow mesenchymal stem cells (BM‑MSCs) treated with N‑CSF and HTH‑CSF after 7 days. Non‑treated BM‑MSCs (A), BM‑MSCs 
exposed to N‑CSF (5% v/v) (B), BM‑MSCs exposed to HTH‑CSF (5% v/v) (C), and BM‑MSCs exposed to HTH‑CSF (10% v/v) (D), (x100). Arrow: spindle‑shaped 
MSCs, thick arrow: neurite outgrowth, star: degenerated cells.
Fig. 1. The effects of N‑CSF and HTH‑CSF on viability of BM‑MSCs. To define 
the most effective dose, different concentration of HTH‑CSF (5%,7% and 
10% v/v) were determined via MTT assay in 72 h. Data are represented as 
mean ± SEM (***P≤0.001, **P≤0.01) compared to controls.
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DISCUSSION
Numerous studies have demonstrated that thyroid 
hormones play an essential role in brain develop‑
ment and neurogenesis. Hypothyroxinemia in moth‑
ers during the gestational and early postnatal period 
has been shown to result in behavioral impairments 
and neurological defects in children (Miranda and 
Sousa, 2018). In the present study, we demonstrat‑
ed that maternal hypothyroidism is associated with 
reduced neurogenesis in BM‑MSCs. Previous studies 
have shown that maternal thyroid hormone deficien‑
cy leads to decreased proliferation and impaired neu‑
rogenesis in the developing neo‑cortex of the fetus 
(Mohan et al., 2012). Our results indicate that hypo‑
thyroidism suppresses neural differentiation in Wis‑
tar rat BM‑MSCs. Shafiee and colleagues (2016) have 
demonstrated that hypothyroidism during the fetal 
and early postnatal periods is associated with an im‑
pairment in spatial learning and memory, and a re‑
duction in hippocampal BDNF levels in both male and 
female rat offspring. Our results add to these data by 
showing that HTH‑CSF induces morphological chang‑
es and decreased neurite growth in BM‑MSCs. Previ‑
ous studies have shown that maternal hypothyroid‑
ism during pregnancy restricts neurite outgrowth 
and induces abnormal neuronal location and synaptic 
impairment (Miranda and Sousa, 2018). Moreover, TH 
deficiency leads to morphological alterations in the 
cortex which may be due to altered development of 
axodendritic processes wherein cells become small‑
er and more closely aggregated than under typical 
conditions (Ahmed et al., 2008). Our morpholog‑
ical assessments showed an aggregation of cells 
and shorter dendrite process among cells exposed 
to hypothyroidism CSF. In the current study, neu‑
ral differentiation was characterized by expression 
of neural markers. In particular, Nestin expression 
is used as a marker for neural stem cells, predomi‑
nantly during early development in embryonic and 
adult brain tissue. Stem and neural progenitor cells 
have been shown to express Nestin during prolifera‑
tion (Liu et al., 2015). Our results demonstrated that 
Nestin expression decreased in BM‑MSCs treated with 
HTH‑CSF as compared with N‑CSF. Neurod‑1 is a basic 
helix‑loop‑helix (bHLH) transcription factor that is 
expressed in the central and peripheral nervous sys‑
tems late in development, and plays an important 
role in embryonic brain development and adult neu‑
rogenesis (Pataskar et al., 2016). Our findings show 
that expression of Neurod‑1 significantly decreases in 
BM‑MSCs treated with hypothyroidism CSF as com‑
pared with N‑CSF and control conditions. Neuronal 
nuclei (NeuN) is a neuron‑specific marker that is used 
to examine the differentiation of stem cells. NeuN ap‑
pears during early embryogenesis in postmitotic neu‑
roblasts and remains in differentiating and terminal‑
ly differentiated neurons (Gusel’nikova et al., 2015). 
We found a downregulation of NeuN in cells exposed 
to HTH‑CSF as compared to those exposed to N‑CSF. 
Thus, the effects of thyroid hormones on neural dif‑
ferentiation and survival is mediated by controlling 
the expression of neurotrophins. Furthermore, previ‑
ous research shows that interactions between thyroid 
hormone and neurotrophic factors such as NGF are 
important for growth and maintenance of cholinergic 
neurons in the basal forebrain (Bernal 2015). Our re‑
sults reveal that induction of maternal hypothyroid‑
ism can inhibit neural differentiation in rat BM‑MSCs. 
CSF contains neurotrophic and growth factors which 
Fig.  3. Neurite outgrowth of BM‑MSCs. Cells were cultured for a  week 
without CSF treatment (i.e., control condition), and then exposed to 
N‑CSF and HTH‑CSF (5% v/v). Neurite length was measured in each group. 
Treatment with HTH‑CSF resulted in a  significant decrease in neurite 
length as compared with N‑CSF. Data are represented as mean ± SEM 
(***P≤0.001, **P≤0.01) compared to the control condition.
Fig.  4. Expression of neuronal markers in BM‑MSCs. The expression of 
(A) Nestin [(5% v/v) N‑CSF, (5% v/v) HTH‑CSF], (B) Neurod‑1 [(5% v/v) N‑CSF 
and (5% v/v) HTH‑CSF] and (C) NeuN [(5% v/v) N‑CSF and (5% v/v) HTH‑CSF] 
are shown. Data are represented as mean ± SEM (***P≤0.001, **P≤0.01, 
*P<0.05) compared to the control.
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have been shown to support the viability, prolifera‑
tion, and differentiation of BM‑MSCs. Results of the 
present study suggest that levels of neural markers 
in hypothyroidism CSF were lower than in N‑CSF, 
and this reduction inhibited neural differentiation of 
BM‑MSCs.
CONCLUSION
Previous studies have demonstrated the importance 
of both thyroid hormones and CSF for neurogenesis 
and development. In this study, we demonstrated that 
maternal hypothyroidism CSF can decrease neural dif‑
ferentiation of mesenchymal stem cells and disrupt 
neurogenesis and brain development of offspring. 
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